mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |